Rank | Gene Set | Z-score |
---|---|---|
1 | signal peptide processing (GO:0006465) | 7.84557178 |
2 | Golgi transport vesicle coating (GO:0048200) | 6.71873901 |
3 | COPI coating of Golgi vesicle (GO:0048205) | 6.71873901 |
4 | protein maturation by protein folding (GO:0022417) | 6.20168492 |
5 | GDP-mannose metabolic process (GO:0019673) | 6.00829615 |
6 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.50599722 |
7 | proteasome assembly (GO:0043248) | 5.27349617 |
8 | ER overload response (GO:0006983) | 5.08058630 |
9 | cullin deneddylation (GO:0010388) | 5.07985517 |
10 | COPII vesicle coating (GO:0048208) | 4.84647951 |
11 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.74909014 |
12 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.61933776 |
13 | protein deneddylation (GO:0000338) | 4.60694823 |
14 | protein retention in ER lumen (GO:0006621) | 4.60483239 |
15 | polyketide metabolic process (GO:0030638) | 4.57119672 |
16 | doxorubicin metabolic process (GO:0044598) | 4.57119672 |
17 | daunorubicin metabolic process (GO:0044597) | 4.57119672 |
18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.41310040 |
19 | ATP synthesis coupled proton transport (GO:0015986) | 4.41310040 |
20 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.40524343 |
21 | endocrine pancreas development (GO:0031018) | 4.39441903 |
22 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.36106536 |
23 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.28566578 |
24 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.26654074 |
25 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.24857242 |
26 | glandular epithelial cell differentiation (GO:0002067) | 4.23717410 |
27 | negative regulation of ligase activity (GO:0051352) | 4.20688905 |
28 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.20688905 |
29 | cytochrome complex assembly (GO:0017004) | 4.18311107 |
30 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.16122367 |
31 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.14791191 |
32 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.14791191 |
33 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.08358610 |
34 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.06845508 |
35 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.06845508 |
36 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.06845508 |
37 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.04367641 |
38 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.04367641 |
39 | peptide hormone processing (GO:0016486) | 4.03223951 |
40 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.91570543 |
41 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.91570543 |
42 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.88318356 |
43 | sequestering of metal ion (GO:0051238) | 3.87202328 |
44 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.79550384 |
45 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.79501900 |
46 | cytidine metabolic process (GO:0046087) | 3.77287773 |
47 | cytidine catabolic process (GO:0006216) | 3.77287773 |
48 | cytidine deamination (GO:0009972) | 3.77287773 |
49 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.74751860 |
50 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.74541492 |
51 | intestinal epithelial cell development (GO:0060576) | 3.66603034 |
52 | quinone metabolic process (GO:1901661) | 3.66520360 |
53 | protein complex biogenesis (GO:0070271) | 3.66157295 |
54 | pseudouridine synthesis (GO:0001522) | 3.64705845 |
55 | positive regulation of ligase activity (GO:0051351) | 3.61792442 |
56 | chaperone-mediated protein transport (GO:0072321) | 3.60482597 |
57 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.58449372 |
58 | termination of RNA polymerase III transcription (GO:0006386) | 3.58179934 |
59 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.58179934 |
60 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.54253142 |
61 | peptidyl-asparagine modification (GO:0018196) | 3.51085369 |
62 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.43217473 |
63 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.43013781 |
64 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.40722779 |
65 | maintenance of protein localization in organelle (GO:0072595) | 3.37229591 |
66 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.37056288 |
67 | phenol-containing compound catabolic process (GO:0019336) | 3.34913385 |
68 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.32878294 |
69 | NADH dehydrogenase complex assembly (GO:0010257) | 3.32878294 |
70 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.32878294 |
71 | peptidyl-histidine modification (GO:0018202) | 3.32240191 |
72 | protein N-linked glycosylation (GO:0006487) | 3.32193855 |
73 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.31791419 |
74 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.31385326 |
75 | electron transport chain (GO:0022900) | 3.27587288 |
76 | exocrine pancreas development (GO:0031017) | 3.27339261 |
77 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.25828801 |
78 | respiratory electron transport chain (GO:0022904) | 3.25684970 |
79 | hormone catabolic process (GO:0042447) | 3.25336605 |
80 | protein targeting to mitochondrion (GO:0006626) | 3.24734991 |
81 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.22340918 |
82 | maturation of 5.8S rRNA (GO:0000460) | 3.21885871 |
83 | DNA damage response, detection of DNA damage (GO:0042769) | 3.18899348 |
84 | rRNA methylation (GO:0031167) | 3.18807584 |
85 | regulation of ligase activity (GO:0051340) | 3.18572449 |
86 | protein K6-linked ubiquitination (GO:0085020) | 3.18182349 |
87 | regulation of cilium movement (GO:0003352) | 3.18109512 |
88 | regulation of cellular amine metabolic process (GO:0033238) | 3.17680999 |
89 | rRNA modification (GO:0000154) | 3.16921266 |
90 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.15568932 |
91 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.15213340 |
92 | cell redox homeostasis (GO:0045454) | 3.13219647 |
93 | coenzyme catabolic process (GO:0009109) | 3.12706657 |
94 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.12397465 |
95 | amino acid salvage (GO:0043102) | 3.10627918 |
96 | L-methionine salvage (GO:0071267) | 3.10627918 |
97 | L-methionine biosynthetic process (GO:0071265) | 3.10627918 |
98 | GTP biosynthetic process (GO:0006183) | 3.10513669 |
99 | establishment of protein localization to mitochondrion (GO:0072655) | 3.09558717 |
100 | positive regulation of cell cycle arrest (GO:0071158) | 3.08490439 |
101 | protein localization to mitochondrion (GO:0070585) | 3.07812219 |
102 | positive regulation of nuclease activity (GO:0032075) | 3.07563890 |
103 | ubiquinone biosynthetic process (GO:0006744) | 3.05847710 |
104 | branched-chain amino acid catabolic process (GO:0009083) | 3.04477533 |
105 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.03921827 |
106 | protein-cofactor linkage (GO:0018065) | 3.01034165 |
107 | mannosylation (GO:0097502) | 3.00623511 |
108 | tRNA processing (GO:0008033) | 2.99840122 |
109 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.98695679 |
110 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.97785088 |
111 | somite rostral/caudal axis specification (GO:0032525) | 2.97367155 |
112 | negative regulation of protein ubiquitination (GO:0031397) | 2.95686670 |
113 | nucleotide-sugar metabolic process (GO:0009225) | 2.93881544 |
114 | DNA replication checkpoint (GO:0000076) | 2.92727089 |
115 | protein neddylation (GO:0045116) | 2.92507143 |
116 | response to redox state (GO:0051775) | 2.91884894 |
117 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.91574626 |
118 | chromatin remodeling at centromere (GO:0031055) | 2.90794355 |
119 | tRNA metabolic process (GO:0006399) | 2.90773073 |
120 | cellular response to topologically incorrect protein (GO:0035967) | 2.90462787 |
121 | DNA deamination (GO:0045006) | 2.87833787 |
122 | cotranslational protein targeting to membrane (GO:0006613) | 2.85736352 |
123 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.84284896 |
124 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.84284896 |
125 | cellular response to unfolded protein (GO:0034620) | 2.83708507 |
126 | regulation of mitochondrial translation (GO:0070129) | 2.83486303 |
127 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.83232972 |
128 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.83118201 |
129 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.82422970 |
130 | UTP biosynthetic process (GO:0006228) | 2.81719367 |
131 | regulation of nuclease activity (GO:0032069) | 2.81698626 |
132 | protein targeting to ER (GO:0045047) | 2.81626771 |
133 | response to misfolded protein (GO:0051788) | 2.80658274 |
134 | fatty acid elongation (GO:0030497) | 2.80475663 |
135 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.80036182 |
136 | response to dietary excess (GO:0002021) | 2.79850292 |
137 | ubiquinone metabolic process (GO:0006743) | 2.79182139 |
138 | respiratory chain complex IV assembly (GO:0008535) | 2.78985193 |
139 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.78037087 |
140 | CENP-A containing nucleosome assembly (GO:0034080) | 2.77863316 |
141 | spliceosomal snRNP assembly (GO:0000387) | 2.77247523 |
142 | protein localization to endoplasmic reticulum (GO:0070972) | 2.75259878 |
143 | nucleoside transmembrane transport (GO:1901642) | 2.74590739 |
144 | intracellular protein transmembrane import (GO:0044743) | 2.74185807 |
145 | replication fork processing (GO:0031297) | 2.74052952 |
146 | DNA double-strand break processing (GO:0000729) | 2.73835050 |
147 | response to endoplasmic reticulum stress (GO:0034976) | 2.72957712 |
148 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.72672457 |
149 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.72312334 |
150 | C-terminal protein lipidation (GO:0006501) | 2.71605675 |
151 | regulation of microtubule-based movement (GO:0060632) | 2.71365125 |
152 | regulation of autophagic vacuole assembly (GO:2000785) | 2.70194105 |
153 | 7-methylguanosine mRNA capping (GO:0006370) | 2.68155847 |
154 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.68150613 |
155 | regulation of cell cycle arrest (GO:0071156) | 2.67893863 |
156 | amino acid activation (GO:0043038) | 2.67639058 |
157 | tRNA aminoacylation (GO:0043039) | 2.67639058 |
158 | proline biosynthetic process (GO:0006561) | 2.67492883 |
159 | signal transduction in response to DNA damage (GO:0042770) | 2.67184070 |
160 | GPI anchor biosynthetic process (GO:0006506) | 2.66026201 |
161 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.66019078 |
162 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.65875700 |
163 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.65351356 |
164 | vesicle coating (GO:0006901) | 2.65247730 |
165 | tRNA aminoacylation for protein translation (GO:0006418) | 2.63239680 |
166 | CTP metabolic process (GO:0046036) | 2.63070283 |
167 | ER-nucleus signaling pathway (GO:0006984) | 2.62887754 |
168 | regulation of hexokinase activity (GO:1903299) | 2.61269437 |
169 | regulation of glucokinase activity (GO:0033131) | 2.61269437 |
170 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.60490712 |
171 | muscle organ morphogenesis (GO:0048644) | 2.58581958 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 5.46660145 |
2 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.40842823 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.58198900 |
4 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 4.30504650 |
5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.98264091 |
6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.87756951 |
7 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.65920261 |
8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.46781567 |
9 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.34398698 |
10 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.34398698 |
11 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.34398698 |
12 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.08223522 |
13 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.97603920 |
14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.63268545 |
15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.61103199 |
16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.37198322 |
17 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.36899588 |
18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28863439 |
19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.22010248 |
20 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.19416235 |
21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.19103815 |
22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.13591495 |
23 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.13568186 |
24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12027962 |
25 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.07589398 |
26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.06999316 |
27 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.04183848 |
28 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.01733576 |
29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95729347 |
30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.95558199 |
31 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.95153656 |
32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.91286169 |
33 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.88665664 |
34 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.88511426 |
35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.86337315 |
36 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.85422555 |
37 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.83797726 |
38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.82130561 |
39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.78323135 |
40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71185750 |
41 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.66360063 |
42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.66035565 |
43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64677951 |
44 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64199121 |
45 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.63763245 |
46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60986551 |
47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55353943 |
48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.49907267 |
49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.42421365 |
50 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.41229632 |
51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36984622 |
52 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33316584 |
53 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.33020753 |
54 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.31694893 |
55 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30775292 |
56 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30390428 |
57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.28617231 |
58 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.28194304 |
59 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.27751961 |
60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27723375 |
61 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.27515718 |
62 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.23513360 |
63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20047329 |
64 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19102381 |
65 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18421601 |
66 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.14966572 |
67 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.14194204 |
68 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.13343642 |
69 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12438567 |
70 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11195930 |
71 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.07960687 |
72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06516219 |
73 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05997989 |
74 | EWS_26573619_Chip-Seq_HEK293_Human | 1.04897399 |
75 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03865238 |
76 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03480587 |
77 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03254635 |
78 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02469846 |
79 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.00858093 |
80 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.99724880 |
81 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98993217 |
82 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.98061946 |
83 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.97674971 |
84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95404745 |
85 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94946241 |
86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94556080 |
87 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94044335 |
88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93332679 |
89 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.93309552 |
90 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.90078328 |
91 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.87904005 |
92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87148977 |
93 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.85319173 |
94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84250322 |
95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83400438 |
96 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.82185728 |
97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.82185728 |
98 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.82053028 |
99 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.82029855 |
100 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81738399 |
101 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.81336505 |
102 | FUS_26573619_Chip-Seq_HEK293_Human | 0.80267117 |
103 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.79043202 |
104 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78594913 |
105 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.78251833 |
106 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.76493494 |
107 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.76262684 |
108 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.76152257 |
109 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.74994918 |
110 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.74967985 |
111 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.72885250 |
112 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.71813256 |
113 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.71629906 |
114 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.70078879 |
115 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69758579 |
116 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.69720138 |
117 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.69268617 |
118 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69205356 |
119 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.69043951 |
120 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.68820211 |
121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68606273 |
122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68501788 |
123 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.68432871 |
124 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.67805827 |
125 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.67728095 |
126 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.67149872 |
127 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.66795081 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004043_abnormal_pH_regulation | 4.67515284 |
2 | MP0000678_abnormal_parathyroid_gland | 3.74961124 |
3 | MP0003183_abnormal_peptide_metabolism | 3.50197449 |
4 | MP0004264_abnormal_extraembryonic_tissu | 3.47323601 |
5 | MP0003195_calcinosis | 3.44368120 |
6 | MP0008058_abnormal_DNA_repair | 3.32414172 |
7 | MP0002877_abnormal_melanocyte_morpholog | 3.06997785 |
8 | MP0003718_maternal_effect | 2.89887783 |
9 | MP0003806_abnormal_nucleotide_metabolis | 2.85879784 |
10 | MP0010386_abnormal_urinary_bladder | 2.84126166 |
11 | MP0002693_abnormal_pancreas_physiology | 2.79721736 |
12 | MP0003122_maternal_imprinting | 2.60843766 |
13 | MP0003890_abnormal_embryonic-extraembry | 2.50325089 |
14 | MP0003283_abnormal_digestive_organ | 2.50148506 |
15 | MP0002102_abnormal_ear_morphology | 2.43960412 |
16 | MP0005220_abnormal_exocrine_pancreas | 2.43167624 |
17 | MP0001944_abnormal_pancreas_morphology | 2.40983661 |
18 | MP0004147_increased_porphyrin_level | 2.33194334 |
19 | MP0010094_abnormal_chromosome_stability | 2.31782811 |
20 | MP0005379_endocrine/exocrine_gland_phen | 2.20600598 |
21 | MP0003646_muscle_fatigue | 2.15874965 |
22 | MP0006035_abnormal_mitochondrial_morpho | 2.09587763 |
23 | MP0002876_abnormal_thyroid_physiology | 2.08627642 |
24 | MP0006292_abnormal_olfactory_placode | 2.00641092 |
25 | MP0002837_dystrophic_cardiac_calcinosis | 1.97590737 |
26 | MP0000013_abnormal_adipose_tissue | 1.93984267 |
27 | MP0002139_abnormal_hepatobiliary_system | 1.93691941 |
28 | MP0001666_abnormal_nutrient_absorption | 1.91482044 |
29 | MP0005257_abnormal_intraocular_pressure | 1.90120332 |
30 | MP0003786_premature_aging | 1.88850849 |
31 | MP0008877_abnormal_DNA_methylation | 1.82632738 |
32 | MP0006072_abnormal_retinal_apoptosis | 1.74629279 |
33 | MP0003186_abnormal_redox_activity | 1.73991228 |
34 | MP0003011_delayed_dark_adaptation | 1.68222777 |
35 | MP0006036_abnormal_mitochondrial_physio | 1.65210998 |
36 | MP0002736_abnormal_nociception_after | 1.65177496 |
37 | MP0002277_abnormal_respiratory_mucosa | 1.64613261 |
38 | MP0005499_abnormal_olfactory_system | 1.63412329 |
39 | MP0005394_taste/olfaction_phenotype | 1.63412329 |
40 | MP0002638_abnormal_pupillary_reflex | 1.62176175 |
41 | MP0002909_abnormal_adrenal_gland | 1.57980071 |
42 | MP0008872_abnormal_physiological_respon | 1.56659600 |
43 | MP0003077_abnormal_cell_cycle | 1.55425939 |
44 | MP0008007_abnormal_cellular_replicative | 1.55137457 |
45 | MP0002078_abnormal_glucose_homeostasis | 1.52775900 |
46 | MP0002163_abnormal_gland_morphology | 1.48584400 |
47 | MP0005365_abnormal_bile_salt | 1.47807949 |
48 | MP0003111_abnormal_nucleus_morphology | 1.46993215 |
49 | MP0000427_abnormal_hair_cycle | 1.38480976 |
50 | MP0005551_abnormal_eye_electrophysiolog | 1.37981517 |
51 | MP0005408_hypopigmentation | 1.37904998 |
52 | MP0009379_abnormal_foot_pigmentation | 1.36929046 |
53 | MP0003868_abnormal_feces_composition | 1.36335758 |
54 | MP0004957_abnormal_blastocyst_morpholog | 1.36335541 |
55 | MP0001529_abnormal_vocalization | 1.31798962 |
56 | MP0009046_muscle_twitch | 1.31375766 |
57 | MP0009780_abnormal_chondrocyte_physiolo | 1.29210267 |
58 | MP0005636_abnormal_mineral_homeostasis | 1.28431350 |
59 | MP0001968_abnormal_touch/_nociception | 1.28417296 |
60 | MP0008789_abnormal_olfactory_epithelium | 1.25664938 |
61 | MP0003136_yellow_coat_color | 1.24906587 |
62 | MP0005360_urolithiasis | 1.24849177 |
63 | MP0002160_abnormal_reproductive_system | 1.24237659 |
64 | MP0009643_abnormal_urine_homeostasis | 1.21195502 |
65 | MP0002090_abnormal_vision | 1.20504058 |
66 | MP0002210_abnormal_sex_determination | 1.18877946 |
67 | MP0004782_abnormal_surfactant_physiolog | 1.17618209 |
68 | MP0000462_abnormal_digestive_system | 1.17590968 |
69 | MP0005646_abnormal_pituitary_gland | 1.17299543 |
70 | MP0005389_reproductive_system_phenotype | 1.17022636 |
71 | MP0001764_abnormal_homeostasis | 1.16180163 |
72 | MP0002295_abnormal_pulmonary_circulatio | 1.16052801 |
73 | MP0002254_reproductive_system_inflammat | 1.15616255 |
74 | MP0000613_abnormal_salivary_gland | 1.15399767 |
75 | MP0000749_muscle_degeneration | 1.13301302 |
76 | MP0001919_abnormal_reproductive_system | 1.10428185 |
77 | MP0005058_abnormal_lysosome_morphology | 1.07489347 |
78 | MP0003123_paternal_imprinting | 1.06690872 |
79 | MP0001929_abnormal_gametogenesis | 1.05552504 |
80 | MP0005266_abnormal_metabolism | 1.04267338 |
81 | MP0001905_abnormal_dopamine_level | 1.03897506 |
82 | MP0000049_abnormal_middle_ear | 1.02529731 |
83 | MP0001542_abnormal_bone_strength | 1.01651831 |
84 | MP0002234_abnormal_pharynx_morphology | 1.00452319 |
85 | MP0005395_other_phenotype | 1.00359436 |
86 | MP0000538_abnormal_urinary_bladder | 0.98954351 |
87 | MP0000358_abnormal_cell_content/ | 0.98609404 |
88 | MP0005084_abnormal_gallbladder_morpholo | 0.98223659 |
89 | MP0005083_abnormal_biliary_tract | 0.97741442 |
90 | MP0005085_abnormal_gallbladder_physiolo | 0.97252226 |
91 | MP0004858_abnormal_nervous_system | 0.96537163 |
92 | MP0002095_abnormal_skin_pigmentation | 0.96241541 |
93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96028189 |
94 | MP0002751_abnormal_autonomic_nervous | 0.95763746 |
95 | MP0003693_abnormal_embryo_hatching | 0.94714340 |
96 | MP0005376_homeostasis/metabolism_phenot | 0.94534647 |
97 | MP0000372_irregular_coat_pigmentation | 0.93067260 |
98 | MP0000653_abnormal_sex_gland | 0.92003820 |
99 | MP0005075_abnormal_melanosome_morpholog | 0.91613666 |
100 | MP0006082_CNS_inflammation | 0.90565144 |
101 | MP0005253_abnormal_eye_physiology | 0.90520249 |
102 | MP0004019_abnormal_vitamin_homeostasis | 0.89989657 |
103 | MP0001145_abnormal_male_reproductive | 0.87759554 |
104 | MP0001293_anophthalmia | 0.87629684 |
105 | MP0003950_abnormal_plasma_membrane | 0.87199810 |
106 | MP0002653_abnormal_ependyma_morphology | 0.87176369 |
107 | MP0003953_abnormal_hormone_level | 0.86592627 |
108 | MP0005310_abnormal_salivary_gland | 0.86424806 |
109 | MP0004215_abnormal_myocardial_fiber | 0.86334492 |
110 | MP0004133_heterotaxia | 0.86089168 |
111 | MP0004142_abnormal_muscle_tone | 0.86021230 |
112 | MP0003119_abnormal_digestive_system | 0.84765269 |
113 | MP0005410_abnormal_fertilization | 0.84594422 |
114 | MP0001984_abnormal_olfaction | 0.84418112 |
115 | MP0000647_abnormal_sebaceous_gland | 0.84400979 |
116 | MP0001727_abnormal_embryo_implantation | 0.83410043 |
117 | MP0005367_renal/urinary_system_phenotyp | 0.82668837 |
118 | MP0000516_abnormal_urinary_system | 0.82668837 |
119 | MP0001986_abnormal_taste_sensitivity | 0.81821640 |
120 | MP0000762_abnormal_tongue_morphology | 0.81698402 |
121 | MP0002332_abnormal_exercise_endurance | 0.81598859 |
122 | MP0001661_extended_life_span | 0.80402344 |
123 | MP0001756_abnormal_urination | 0.80073379 |
124 | MP0001765_abnormal_ion_homeostasis | 0.79487983 |
125 | MP0003937_abnormal_limbs/digits/tail_de | 0.79280441 |
126 | MP0003121_genomic_imprinting | 0.78935213 |
127 | MP0002938_white_spotting | 0.77651941 |
128 | MP0005645_abnormal_hypothalamus_physiol | 0.77628214 |
129 | MP0001664_abnormal_digestion | 0.77439379 |
130 | MP0005332_abnormal_amino_acid | 0.77437513 |
131 | MP0002734_abnormal_mechanical_nocicepti | 0.77226701 |
132 | MP0008932_abnormal_embryonic_tissue | 0.77046303 |
133 | MP0003959_abnormal_lean_body | 0.76694026 |
134 | MP0000631_abnormal_neuroendocrine_gland | 0.76030651 |
135 | MP0004381_abnormal_hair_follicle | 0.73155514 |
136 | MP0006276_abnormal_autonomic_nervous | 0.73026176 |
137 | MP0002098_abnormal_vibrissa_morphology | 0.72923930 |
138 | MP0002127_abnormal_cardiovascular_syste | 0.72888489 |
139 | MP0001119_abnormal_female_reproductive | 0.72864083 |
140 | MP0005319_abnormal_enzyme/_coenzyme | 0.72791245 |
141 | MP0003698_abnormal_male_reproductive | 0.72482847 |
142 | MP0009697_abnormal_copulation | 0.72378045 |
143 | MP0010030_abnormal_orbit_morphology | 0.70518836 |
144 | MP0000681_abnormal_thyroid_gland | 0.70289842 |
145 | MP0005174_abnormal_tail_pigmentation | 0.69850761 |
146 | MP0000003_abnormal_adipose_tissue | 0.68853494 |
147 | MP0004270_analgesia | 0.68668940 |
148 | MP0002229_neurodegeneration | 0.68658696 |
149 | MP0003252_abnormal_bile_duct | 0.67398558 |
150 | MP0001324_abnormal_eye_pigmentation | 0.62874355 |
151 | MP0008775_abnormal_heart_ventricle | 0.61927114 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.75872651 |
2 | Type I transferrin isoform profile (HP:0003642) | 4.48167024 |
3 | Acute necrotizing encephalopathy (HP:0006965) | 4.39812240 |
4 | Symptomatic seizures (HP:0011145) | 3.99478836 |
5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.99046065 |
6 | Hypoglycemic coma (HP:0001325) | 3.79300078 |
7 | Abnormal protein glycosylation (HP:0012346) | 3.77603318 |
8 | Abnormal glycosylation (HP:0012345) | 3.77603318 |
9 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.77603318 |
10 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.77603318 |
11 | Hypoglycemic seizures (HP:0002173) | 3.77057713 |
12 | Abnormality of the intrinsic pathway (HP:0010989) | 3.72197349 |
13 | Acute encephalopathy (HP:0006846) | 3.66362593 |
14 | Progressive macrocephaly (HP:0004481) | 3.51278173 |
15 | Reduced antithrombin III activity (HP:0001976) | 3.36333362 |
16 | Increased serum pyruvate (HP:0003542) | 3.33182504 |
17 | Abnormality of glycolysis (HP:0004366) | 3.33182504 |
18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.31282207 |
19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.31282207 |
20 | Mitochondrial inheritance (HP:0001427) | 3.29967747 |
21 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.19143065 |
22 | Hypoplasia of the fovea (HP:0007750) | 3.19143065 |
23 | Generalized aminoaciduria (HP:0002909) | 3.15322909 |
24 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.99258753 |
25 | Hepatic necrosis (HP:0002605) | 2.96693985 |
26 | Abnormal pancreas size (HP:0012094) | 2.94761378 |
27 | Increased CSF lactate (HP:0002490) | 2.92941755 |
28 | Microvesicular hepatic steatosis (HP:0001414) | 2.90490515 |
29 | Increased intramyocellular lipid droplets (HP:0012240) | 2.81339160 |
30 | Bifid tongue (HP:0010297) | 2.80112223 |
31 | Multiple enchondromatosis (HP:0005701) | 2.79646124 |
32 | Hepatoblastoma (HP:0002884) | 2.75472253 |
33 | Abnormality of the fovea (HP:0000493) | 2.71002785 |
34 | 3-Methylglutaconic aciduria (HP:0003535) | 2.70698509 |
35 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.68940900 |
36 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.67972689 |
37 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.67972689 |
38 | Bilateral microphthalmos (HP:0007633) | 2.67254342 |
39 | Renal Fanconi syndrome (HP:0001994) | 2.61721325 |
40 | Ketoacidosis (HP:0001993) | 2.61491918 |
41 | Meckel diverticulum (HP:0002245) | 2.60066088 |
42 | Pancreatic cysts (HP:0001737) | 2.58563663 |
43 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.56400630 |
44 | Optic disc pallor (HP:0000543) | 2.53781839 |
45 | Abnormality of the ileum (HP:0001549) | 2.53280602 |
46 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.52539148 |
47 | Cerebral edema (HP:0002181) | 2.49347630 |
48 | Abnormality of urine glucose concentration (HP:0011016) | 2.48141366 |
49 | Glycosuria (HP:0003076) | 2.48141366 |
50 | Hepatocellular necrosis (HP:0001404) | 2.45411571 |
51 | Hyperglycemia (HP:0003074) | 2.44354138 |
52 | Gout (HP:0001997) | 2.40416756 |
53 | CNS demyelination (HP:0007305) | 2.40080063 |
54 | Abnormal pupillary function (HP:0007686) | 2.38170420 |
55 | Dysautonomia (HP:0002459) | 2.37092218 |
56 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.36123664 |
57 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.34485511 |
58 | Pancreatic fibrosis (HP:0100732) | 2.33868376 |
59 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.33133737 |
60 | Abnormality of alanine metabolism (HP:0010916) | 2.33133737 |
61 | Hyperalaninemia (HP:0003348) | 2.33133737 |
62 | Vacuolated lymphocytes (HP:0001922) | 2.30751899 |
63 | Abnormality of the preputium (HP:0100587) | 2.30006372 |
64 | Increased muscle lipid content (HP:0009058) | 2.29964215 |
65 | Exertional dyspnea (HP:0002875) | 2.29587802 |
66 | Conjugated hyperbilirubinemia (HP:0002908) | 2.29131519 |
67 | Hypokinesia (HP:0002375) | 2.25279038 |
68 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.25042148 |
69 | Hyperphosphaturia (HP:0003109) | 2.24440900 |
70 | Type 2 muscle fiber atrophy (HP:0003554) | 2.24349465 |
71 | Progressive muscle weakness (HP:0003323) | 2.23907246 |
72 | Respiratory difficulties (HP:0002880) | 2.22136226 |
73 | Osteomalacia (HP:0002749) | 2.21845856 |
74 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.21606248 |
75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21156720 |
76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21156720 |
77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21156720 |
78 | Chromsome breakage (HP:0040012) | 2.20856201 |
79 | Methylmalonic aciduria (HP:0012120) | 2.19790892 |
80 | Exercise intolerance (HP:0003546) | 2.18413334 |
81 | Cortical visual impairment (HP:0100704) | 2.16931159 |
82 | Testicular atrophy (HP:0000029) | 2.16755957 |
83 | Pendular nystagmus (HP:0012043) | 2.15208810 |
84 | Abnormality of midbrain morphology (HP:0002418) | 2.15205045 |
85 | Molar tooth sign on MRI (HP:0002419) | 2.15205045 |
86 | Hyperglycinemia (HP:0002154) | 2.14559282 |
87 | Cerebral hypomyelination (HP:0006808) | 2.09607374 |
88 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.09493098 |
89 | Methylmalonic acidemia (HP:0002912) | 2.08789175 |
90 | Poor head control (HP:0002421) | 2.07516872 |
91 | Ragged-red muscle fibers (HP:0003200) | 2.06123817 |
92 | Opisthotonus (HP:0002179) | 2.05296492 |
93 | Respiratory failure (HP:0002878) | 2.05130920 |
94 | Trismus (HP:0000211) | 2.04740021 |
95 | True hermaphroditism (HP:0010459) | 2.04637867 |
96 | Pheochromocytoma (HP:0002666) | 2.03382251 |
97 | Late onset (HP:0003584) | 2.01364168 |
98 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.97716328 |
99 | Nephronophthisis (HP:0000090) | 1.97148597 |
100 | Leukodystrophy (HP:0002415) | 1.97130542 |
101 | Neuroendocrine neoplasm (HP:0100634) | 1.96547515 |
102 | Large for gestational age (HP:0001520) | 1.96462485 |
103 | X-linked dominant inheritance (HP:0001423) | 1.96299582 |
104 | Increased hepatocellular lipid droplets (HP:0006565) | 1.95531537 |
105 | Dysostosis multiplex (HP:0000943) | 1.95221123 |
106 | Muscle fiber atrophy (HP:0100295) | 1.95131231 |
107 | Reticulocytopenia (HP:0001896) | 1.93344996 |
108 | Increased serum lactate (HP:0002151) | 1.92851505 |
109 | Abnormality of serum amino acid levels (HP:0003112) | 1.92030535 |
110 | Secondary amenorrhea (HP:0000869) | 1.92022152 |
111 | Medial flaring of the eyebrow (HP:0010747) | 1.91133546 |
112 | Sensory axonal neuropathy (HP:0003390) | 1.90983418 |
113 | Hypoplasia of the uterus (HP:0000013) | 1.90134653 |
114 | Abnormality of renal resorption (HP:0011038) | 1.88686889 |
115 | Emotional lability (HP:0000712) | 1.87426918 |
116 | Lipid accumulation in hepatocytes (HP:0006561) | 1.87403378 |
117 | Abnormality of the pons (HP:0007361) | 1.86233268 |
118 | Hyperparathyroidism (HP:0000843) | 1.85262566 |
119 | CNS hypomyelination (HP:0003429) | 1.85250809 |
120 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.83541725 |
121 | Congenital primary aphakia (HP:0007707) | 1.81700876 |
122 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.81472454 |
123 | Lethargy (HP:0001254) | 1.80966393 |
124 | Facial cleft (HP:0002006) | 1.80578178 |
125 | Abnormality of methionine metabolism (HP:0010901) | 1.79506253 |
126 | Abnormal cartilage morphology (HP:0002763) | 1.78988907 |
127 | Hypothermia (HP:0002045) | 1.78940669 |
128 | Pancytopenia (HP:0001876) | 1.78437100 |
129 | Gait imbalance (HP:0002141) | 1.78012535 |
130 | Blindness (HP:0000618) | 1.77649687 |
131 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.77395811 |
132 | Upper limb muscle weakness (HP:0003484) | 1.77312498 |
133 | Chronic bronchitis (HP:0004469) | 1.77251031 |
134 | Abdominal distention (HP:0003270) | 1.77005781 |
135 | Delayed CNS myelination (HP:0002188) | 1.76995524 |
136 | Absent thumb (HP:0009777) | 1.75399522 |
137 | Abnormality of placental membranes (HP:0011409) | 1.75272811 |
138 | Amniotic constriction ring (HP:0009775) | 1.75272811 |
139 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75236864 |
140 | Abnormality of glycine metabolism (HP:0010895) | 1.75236864 |
141 | Abnormality of chromosome stability (HP:0003220) | 1.74833380 |
142 | Abnormal hemoglobin (HP:0011902) | 1.74424986 |
143 | Progressive microcephaly (HP:0000253) | 1.74385079 |
144 | Villous atrophy (HP:0011473) | 1.74002577 |
145 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.74002577 |
146 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.73106787 |
147 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72237157 |
148 | Dicarboxylic aciduria (HP:0003215) | 1.72237157 |
149 | Lactic acidosis (HP:0003128) | 1.72195451 |
150 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.71803755 |
151 | Hyperglycinuria (HP:0003108) | 1.71263476 |
152 | Sclerocornea (HP:0000647) | 1.70702915 |
153 | Oral leukoplakia (HP:0002745) | 1.68456986 |
154 | Abnormality of the anterior horn cell (HP:0006802) | 1.64336473 |
155 | Degeneration of anterior horn cells (HP:0002398) | 1.64336473 |
156 | Small intestinal stenosis (HP:0012848) | 1.63603691 |
157 | Duodenal stenosis (HP:0100867) | 1.63603691 |
158 | Sparse eyelashes (HP:0000653) | 1.63544376 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.67834419 |
2 | INSRR | 3.44410695 |
3 | VRK2 | 3.20537646 |
4 | PASK | 3.17024742 |
5 | AKT3 | 3.01806987 |
6 | EIF2AK3 | 2.99890143 |
7 | GRK5 | 2.97769590 |
8 | BCKDK | 2.63469869 |
9 | STK16 | 2.59298176 |
10 | MAPK15 | 2.44378194 |
11 | NME1 | 2.42604908 |
12 | NUAK1 | 2.36048145 |
13 | TRIM28 | 2.35074033 |
14 | NME2 | 2.32835926 |
15 | ADRBK2 | 2.26845663 |
16 | MAP4K2 | 2.23556621 |
17 | BRAF | 2.04006372 |
18 | GRK7 | 2.00525817 |
19 | MAP3K12 | 2.00468408 |
20 | FRK | 1.89144288 |
21 | GRK1 | 1.83783392 |
22 | WNK4 | 1.83588016 |
23 | ARAF | 1.76570358 |
24 | CDK12 | 1.75256425 |
25 | EPHA2 | 1.73889199 |
26 | BUB1 | 1.67917055 |
27 | MAPKAPK3 | 1.65619930 |
28 | BMPR1B | 1.63087588 |
29 | MUSK | 1.61485271 |
30 | NTRK1 | 1.54877588 |
31 | HIPK2 | 1.51901767 |
32 | CDC7 | 1.48917606 |
33 | NEK1 | 1.47560174 |
34 | IRAK3 | 1.45490560 |
35 | PBK | 1.44842795 |
36 | MST4 | 1.44209893 |
37 | MAP2K2 | 1.38364681 |
38 | GRK6 | 1.37423945 |
39 | VRK1 | 1.36349147 |
40 | PRKD3 | 1.29994080 |
41 | BCR | 1.28888342 |
42 | ACVR1B | 1.28071895 |
43 | WEE1 | 1.26485856 |
44 | DYRK2 | 1.24337329 |
45 | TESK1 | 1.24212379 |
46 | LIMK1 | 1.22022156 |
47 | MET | 1.17689655 |
48 | MKNK2 | 1.15267772 |
49 | MOS | 1.10560525 |
50 | PHKG1 | 1.06819493 |
51 | PHKG2 | 1.06819493 |
52 | MAP3K3 | 1.05242845 |
53 | CSNK1G1 | 1.03702602 |
54 | EIF2AK1 | 1.03597621 |
55 | PIM2 | 1.03277054 |
56 | MAP3K2 | 1.02254324 |
57 | STK39 | 1.02045491 |
58 | ADRBK1 | 1.00231737 |
59 | BMPR2 | 0.98939758 |
60 | PRKG2 | 0.95390109 |
61 | UHMK1 | 0.91028773 |
62 | PRKCI | 0.89948337 |
63 | WNK1 | 0.88451478 |
64 | MAPK7 | 0.87052956 |
65 | TESK2 | 0.86994191 |
66 | OXSR1 | 0.85922771 |
67 | BRSK1 | 0.83806721 |
68 | PNCK | 0.82654949 |
69 | WNK3 | 0.82163725 |
70 | CASK | 0.80517830 |
71 | PINK1 | 0.80398274 |
72 | PIK3CG | 0.79569419 |
73 | CDK8 | 0.79240016 |
74 | IRAK1 | 0.79140941 |
75 | CSNK1G2 | 0.77763537 |
76 | TAF1 | 0.74957309 |
77 | DAPK1 | 0.74113860 |
78 | PAK3 | 0.72963522 |
79 | CAMK2B | 0.70569413 |
80 | AURKA | 0.69776290 |
81 | TTK | 0.69483017 |
82 | FER | 0.68065665 |
83 | TNIK | 0.65351228 |
84 | ABL2 | 0.65157858 |
85 | MAP2K6 | 0.62125814 |
86 | EIF2AK2 | 0.61650755 |
87 | CSF1R | 0.61198637 |
88 | MAP2K7 | 0.60390874 |
89 | MAPK13 | 0.60052797 |
90 | CAMK2D | 0.59941814 |
91 | PRKCG | 0.59941509 |
92 | CSNK1A1L | 0.59782972 |
93 | MKNK1 | 0.59364014 |
94 | PRKCE | 0.58578151 |
95 | CSNK1A1 | 0.58309519 |
96 | DYRK3 | 0.57725712 |
97 | PAK4 | 0.57094353 |
98 | CCNB1 | 0.56276703 |
99 | TAOK3 | 0.54556579 |
100 | IRAK4 | 0.53729637 |
101 | ATR | 0.53665177 |
102 | STK3 | 0.53211475 |
103 | MAPKAPK5 | 0.52848280 |
104 | PTK2 | 0.52835790 |
105 | AURKB | 0.52731726 |
106 | ILK | 0.51931634 |
107 | MST1R | 0.50712322 |
108 | LATS1 | 0.49772614 |
109 | TLK1 | 0.48629510 |
110 | IRAK2 | 0.46638739 |
111 | CDC42BPA | 0.45781288 |
112 | CSNK2A2 | 0.45755187 |
113 | CSNK1G3 | 0.45745361 |
114 | CHEK2 | 0.45333383 |
115 | ZAK | 0.45171853 |
116 | OBSCN | 0.44079712 |
117 | PAK1 | 0.43595140 |
118 | TSSK6 | 0.43351484 |
119 | MYLK | 0.43179101 |
120 | PRKACA | 0.41062967 |
121 | CSNK2A1 | 0.39654275 |
122 | BRSK2 | 0.39442585 |
123 | DYRK1A | 0.37932844 |
124 | CAMK2G | 0.37810422 |
125 | SRPK1 | 0.37200296 |
126 | IGF1R | 0.36620091 |
127 | FLT3 | 0.34931711 |
128 | PLK4 | 0.34628147 |
129 | ERBB4 | 0.33914613 |
130 | DYRK1B | 0.33633520 |
131 | PLK1 | 0.33506915 |
132 | ERBB3 | 0.33032192 |
133 | RPS6KA5 | 0.32547460 |
134 | MATK | 0.31777359 |
135 | RPS6KB2 | 0.31729699 |
136 | PRKCD | 0.29499960 |
137 | ATM | 0.28686143 |
138 | PLK2 | 0.27706025 |
139 | PDK2 | 0.27460416 |
140 | GSK3A | 0.27341004 |
141 | STK38L | 0.27079960 |
142 | MAP3K4 | 0.27076645 |
143 | PLK3 | 0.26806838 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 6.80702421 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.18961489 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.40434346 |
4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.16872834 |
5 | Proteasome_Homo sapiens_hsa03050 | 2.75745746 |
6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.65998142 |
7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.41177227 |
8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.19117919 |
9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.14361659 |
10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.14008639 |
11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.02980369 |
12 | Mismatch repair_Homo sapiens_hsa03430 | 2.02894180 |
13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.95955253 |
14 | DNA replication_Homo sapiens_hsa03030 | 1.87789517 |
15 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.87397269 |
16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.82887624 |
17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.82794801 |
18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.73719778 |
19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.71749373 |
20 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.69682104 |
21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.68335239 |
22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.65605500 |
23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.65558252 |
24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.58484124 |
25 | Ribosome_Homo sapiens_hsa03010 | 1.58447598 |
26 | RNA polymerase_Homo sapiens_hsa03020 | 1.56826226 |
27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.56656859 |
28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.47573730 |
29 | Base excision repair_Homo sapiens_hsa03410 | 1.42576495 |
30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40408633 |
31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.38357976 |
32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.38228177 |
33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35942132 |
34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33791187 |
35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.33185711 |
36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32652503 |
37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.25055701 |
38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.23575569 |
39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11257044 |
40 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.08306576 |
41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07821023 |
42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06423068 |
43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04552813 |
44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04333890 |
45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.04134909 |
46 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.03133556 |
47 | Lysosome_Homo sapiens_hsa04142 | 1.01197114 |
48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00904513 |
49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.97426225 |
50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95411283 |
51 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95380465 |
52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92604418 |
53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90032754 |
54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87968908 |
55 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.86704349 |
56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86357365 |
57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.85985790 |
58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80249981 |
59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78960369 |
60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.76483126 |
61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76347315 |
62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75989601 |
63 | Insulin secretion_Homo sapiens_hsa04911 | 0.75531903 |
64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75246196 |
65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74622966 |
66 | Phototransduction_Homo sapiens_hsa04744 | 0.73590714 |
67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72743635 |
68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71806322 |
69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.70338089 |
70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70169311 |
71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70150226 |
72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69069350 |
73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68541193 |
74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67646970 |
75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64871907 |
76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63053280 |
77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63028754 |
78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59531637 |
79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59389376 |
80 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59358998 |
81 | Phagosome_Homo sapiens_hsa04145 | 0.59245576 |
82 | Cell cycle_Homo sapiens_hsa04110 | 0.58773481 |
83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58547698 |
84 | Peroxisome_Homo sapiens_hsa04146 | 0.55676717 |
85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55523218 |
86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53019668 |
87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52081213 |
88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49696650 |
89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48329577 |
90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47762882 |
91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47370561 |
92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47230416 |
93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45417543 |
94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43450827 |
95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43189627 |
96 | Purine metabolism_Homo sapiens_hsa00230 | 0.43006373 |
97 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41691369 |
98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.39507628 |
99 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38747552 |
100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38650989 |
101 | Prion diseases_Homo sapiens_hsa05020 | 0.34787290 |
102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34164913 |
103 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34078447 |
104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33988477 |
105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33898501 |
106 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32855553 |
107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31989619 |
108 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31589373 |
109 | RNA transport_Homo sapiens_hsa03013 | 0.30996305 |
110 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.30189124 |
111 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.29851834 |
112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25595896 |
113 | Taste transduction_Homo sapiens_hsa04742 | 0.24670282 |
114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24361421 |
115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24288335 |
116 | Homologous recombination_Homo sapiens_hsa03440 | 0.23579676 |
117 | RNA degradation_Homo sapiens_hsa03018 | 0.22550794 |
118 | Carbon metabolism_Homo sapiens_hsa01200 | 0.22103045 |
119 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.21651367 |
120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.20704876 |
121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18775968 |
122 | Legionellosis_Homo sapiens_hsa05134 | 0.17362356 |
123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.15789811 |
124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.15710784 |
125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13554840 |
126 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.13495655 |
127 | Spliceosome_Homo sapiens_hsa03040 | 0.12044962 |
128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.11847605 |
129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11546642 |
130 | Mineral absorption_Homo sapiens_hsa04978 | 0.11196284 |